212 related articles for article (PubMed ID: 19156752)
1. Utilisation of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study.
Markovic-Pekovic V; Stoisavljevic-Satara S; Skrbic R
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):320-6. PubMed ID: 19156752
[TBL] [Abstract][Full Text] [Related]
2. Drug utilisation 90% profiles--a useful tool for quality assessment of prescribing in primary health care in Stockholm.
Wettermark B; Pehrsson A; Jinnerot D; Bergman U
Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):499-510. PubMed ID: 14521137
[TBL] [Abstract][Full Text] [Related]
3. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
Chiang CW; Chen CY; Chiu HF; Wu HL; Yang CY
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613
[TBL] [Abstract][Full Text] [Related]
4. Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up.
Kalinić D; Škrbić R; Vulić D; Stojaković N; Stoisavljević-Šatara S; Stojiljković MP; Marković-Peković V; Golić Jelić A; Pilipović-Broćeta N; Wong ND; Godman B
Front Pharmacol; 2022; 13():889047. PubMed ID: 35784727
[No Abstract] [Full Text] [Related]
5. Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm).
Vlahovic-Palcevski V; Wettermark B; Bergman U
Eur J Clin Pharmacol; 2002 Jun; 58(3):209-14. PubMed ID: 12107607
[TBL] [Abstract][Full Text] [Related]
6. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
Kvan E; Pettersen KI; Landmark K; Reikvam A;
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):261-7. PubMed ID: 16315337
[TBL] [Abstract][Full Text] [Related]
7. The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
Fraeyman J; Van Hal G; Godman B; Beutels P
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):141-51. PubMed ID: 23402454
[TBL] [Abstract][Full Text] [Related]
8. Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions.
Markovic-Pekovic V; Skrbić R; Godman B; Gustafsson LL
Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):661-71. PubMed ID: 23186404
[TBL] [Abstract][Full Text] [Related]
9. Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia & Herzegovina.
Marković-Peković V; Stoisavljević-Satara S; Skrbić R
Eur J Clin Pharmacol; 2010 Feb; 66(2):177-86. PubMed ID: 19816681
[TBL] [Abstract][Full Text] [Related]
10. Financial incentives linked to self-assessment of prescribing patterns: a new approach for quality improvement of drug prescribing in primary care.
Wettermark B; Pehrsson A; Juhasz-Haverinen M; Veg A; Edlert M; Törnwall-Bergendahl G; Almkvist H; Godman B; Granath F; Bergman U
Qual Prim Care; 2009; 17(3):179-89. PubMed ID: 19622268
[TBL] [Abstract][Full Text] [Related]
11. Eleven-Year Trends in Lipid-Modifying Medicines Utilisation and Expenditure in a Low-Income Country: A Study from the Republic of Srpska, Bosnia and Herzegovina.
Kalinić D; Škrbić R; Vulić D; Stoisavljević-Šatara S; Stojaković N; Stojiljković MP; Marković-Peković V; Golić Jelić A; Pilipović-Broćeta N; Divac N
Clinicoecon Outcomes Res; 2023; 15():513-523. PubMed ID: 37405360
[TBL] [Abstract][Full Text] [Related]
12. Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India.
Tiwari H; Kumar A; Kulkarni SK
Singapore Med J; 2004 Mar; 45(3):117-20. PubMed ID: 15029413
[TBL] [Abstract][Full Text] [Related]
13. Using aggregate data on dispensed drugs to evaluate the quality of prescribing in urban primary health care in Sweden.
Wettermark B; Bergman U; Krakau I
Public Health; 2006 May; 120(5):451-61. PubMed ID: 16513149
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular drug utilisation and socio-economic inequalities in 20 districts of the Czech Republic.
Gorecka K; Linhartova A; Vlcek J; Tilser I
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):417-23. PubMed ID: 15983824
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive drug prescribing in Grampian.
Ross S; Macleod MJ
Br J Clin Pharmacol; 2005 Sep; 60(3):300-5. PubMed ID: 16120069
[TBL] [Abstract][Full Text] [Related]
16. Quality of cardiovascular drugs prescribing in Croatia 2003-2008.
Stimac D
Coll Antropol; 2012 Jan; 36 Suppl 1():189-94. PubMed ID: 22338770
[TBL] [Abstract][Full Text] [Related]
17. Measurement of changes in antihypertensive drug utilisation following primary care educational interventions.
Horn FE; Mandryk JA; Mackson JM; Wutzke SE; Weekes LM; Hyndman RJ
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):297-308. PubMed ID: 16634120
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of utilization of cardiovascular drugs in the Czech Republic and in Wales].
Górecká K; Vlcek J; Walker R
Vnitr Lek; 2003 Aug; 49(8):592-7. PubMed ID: 14518081
[TBL] [Abstract][Full Text] [Related]
19. Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001.
Jackevicius CA; Tu K; Filate WA; Brien SE; Tu JV;
Can J Cardiol; 2003 Nov; 19(12):1359-66. PubMed ID: 14631469
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
